Your browser doesn't support javascript.
loading
The incidences and clinical outcomes of cryptococcosis in Taiwan: A nationwide, population-based study, 2002-2015.
Guan, Shang-Ting; Huang, Yu-Shan; Huang, Shih-Tsung; Hsiao, Fei-Yuan; Chen, Yee-Chun.
Affiliation
  • Guan ST; Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, 2F.-220, No. 33, Linsen S. Rd., Zhongzheng Dist., Taipei City 100025, Taiwan.
  • Huang YS; Health Data Research Center, National Taiwan University, Taipei City 10051, Taiwan.
  • Huang ST; Department of Internal Medicine, National Taiwan University Hospital, Taipei City 100225, Taiwan.
  • Hsiao FY; Department of Pharmacy, National Yang Ming Chiao Tung University, Taipei City 112304, Taiwan.
  • Chen YC; Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei City 112304, Taiwan.
Med Mycol ; 62(1)2024 Jan 09.
Article in En | MEDLINE | ID: mdl-38126122
ABSTRACT
Large-scale epidemiological data on cryptococcosis other than cryptococcal meningitis (CM), human immunodeficiency virus (HIV)- or solid organ transplantation (SOT)-associated cryptococcosis are limited. This study investigated the disease burden of cryptococcosis in Taiwan over 14 years. Incident episodes of cryptococcosis, comorbidities, treatment, and outcomes were captured from Taiwan's National Health Insurance Research Database and National Death Registry between 2002 and 2015. Of 6647 episodes analyzed, the crude incidence rate per 100 000 population increased from 1.48 in 2002 to 2.76 in 2015, which was driven by the growing trend in the non-CM group (0.86-2.12) but not in the CM group (0.62-0.64). The leading three comorbidities were diabetes mellitus (23.62%), malignancy (22.81%), and liver disease (17.42%). HIV accounted for 6.14% of all episodes and was associated with the highest disease-specific incidence rate (269/100 000 population), but the value dropped 16.20% biennially. Within 90 days prior to cohort entry, 30.22% of episodes had systemic corticosteroid use. The in-hospital mortality of all episodes was 10.80%, which varied from 32.64% for cirrhosis and 13.22% for HIV to 6.90% for SOT. CM was associated with a higher in-hospital mortality rate than non-CM (19.15% vs. 6.33%). At diagnosis, only 48.53% of CM episodes were prescribed an amphotericin-based regimen. The incidence rate of cryptococcosis was increasing, especially that other than meningitis and in the non-HIV population. A high index of clinical suspicion is paramount to promptly diagnose, treat, and improve cryptococcosis-related mortality in populations other than those with HIV infection or SOT.
This nationwide study showed that the incidence rate of cryptococcosis doubled from 2002 to 2015. Non-meningeal cryptococcosis and non-HIV/nontransplant (NHNT)-associated cryptococcosis contributed to this increase. Our study highlighted the underestimated burden of cryptococcosis in the NHNT hosts.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: HIV Infections / Meningitis, Cryptococcal / Cryptococcosis / Cryptococcus neoformans Limits: Humans Country/Region as subject: Asia Language: En Journal: Med Mycol Journal subject: MEDICINA VETERINARIA / MICROBIOLOGIA Year: 2024 Type: Article Affiliation country: Taiwan

Full text: 1 Database: MEDLINE Main subject: HIV Infections / Meningitis, Cryptococcal / Cryptococcosis / Cryptococcus neoformans Limits: Humans Country/Region as subject: Asia Language: En Journal: Med Mycol Journal subject: MEDICINA VETERINARIA / MICROBIOLOGIA Year: 2024 Type: Article Affiliation country: Taiwan